Mytesi
Ended Awarded
- Contract number
- 36C26024F0275
- Awardee
-
Napo Pharmaceuticals Inc. UEI GNMTLLK5JQE5 Part of Jaguar Health, Inc.
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $42,225
Award facts
- Contract value 100% obligated
- $42,225.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94104, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Napo Pharmaceuticals Inc., a subsidiary of Jaguar Health Inc. The contract is valued at $42,225.25 and has an ultimate completion date of March 18, 2024. The contract is for the delivery of the pharmaceutical product Mytesi (crofelemer), a 125mg oral tablet used to treat non-infectious diarrhea in adult HIV/AIDS patients receiving antiretroviral therapy.
Napo Pharmaceuticals Inc. holds a Federal Supply Schedule (FSS) contract (ID: 36F79723D0158) under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products, which allows VA healthcare facilities nationwide to efficiently order the specialized medication. This multiple-award Indefinite Delivery Vehicle (IDV) contract has a total value of $1,151,660 and runs from August 1, 2023, through July 31, 2028. The contract does not have a set-aside designation, indicating Napo competes in open market procurement.
Quick answers
Who was awarded contract 36C26024F0275?
36C26024F0275 was awarded to Napo Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 7, 2024.
How much is contract 36C26024F0275 worth?
The government has obligated $42,225 on 36C26024F0275.
Is contract 36C26024F0275 an order under another contract?
Yes. 36C26024F0275 is a delivery order under 36F79723D0158, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0275 competed?
The extent of competition for 36C26024F0275 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award